Helius Medical Technologies is trading 5.34% up at $2.76 before the October 2, 2026 open; no catalyst is confirmed. - Sept. 30: roughly $15 million registered direct offering priced 5% above net asset value. - Proceeds target Solana-per-share growth, potential buybacks and other corporate purposes; close expected around Oct. 1. - No Oct. 2 announcement or causal link was confirmed; sector weakness does not explain the rise. Pre-market volume was not provided.